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Pterygium leading to bilateral blindness and forcing patient to quit job is uncommon. This is a case report of a 46 
year old indigent woman who had blinding pterygia over 10 years. She could not afford pterygium excision 
offered in a private eye clinic where she initially presented after a period of unsuccessful self medication. She 
was forced out of sewing job consequent to her inability to thread needle, difficulty reading number on the tape 
rule and difficulty recognising faces of her clients. Six years later, she presented at eye clinic of the University of 
Ilorin Teaching Hospital, Nigeria with advanced bilateral pterygia. Having defaulted from clinic over 4 months 
for lack of fund, the patient, after concession, had successful bilateral pterygia excision using bare sclera 
technique with Mitomycin C (MMC) dab. There was restoration of the lost vision. Pterygium is a cause of 
avoidable blindness with consequential impact on quality of life. Eye care providers should identify individual 
patient challenges to reduce avoidable blindness. 
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INTRODUCTION 
Pterygium is a common eye condition notorious for 
conjunctiva redness (which may be of cosmetic 
implication), lacrimation, itching / grittiness that 
may cause insomnia/psychological upset and visual 
impairment resulting from induced astigmatism, 
glare, and decreased contrast sensitivity (Lin et al., 
1989). It is a triangular or wing-shaped conjunctiva 
encroachment on the cornea, may be atrophic, 
stationary or progressive (Johnson, 2003; 
Luanratanakorn et al., 2006) and could induce 
diplopia. Histologically, pterygium contains 
elastotic degenerated collagen tissue of the stroma 
of the conjunctiva. It can be unipolar usually nasal, 
or temporal. It can be nasally and temporally 
located, bipolar while bilateral and not necessarily 
symmetrical do occur. There may be cystic changes 
of the lesion and rarely calcification and neoplastic 
transformation are seen (Khamar et al., 2005). 
Pterygium exists worldwide however; it is more 
common in region between latitudes 400 north and 
south of the equator (Johnson, 2003).  Pterygium 
used to be regarded as degenerative disease 
however current evidence suggests a proliferative 
condition, a dysplasia, or even a benign neoplasm 
(Johnson, 2003). Though a number of risk factors 
such as prolonged exposure to warmth, dry and 
dusty environment, and ultraviolet light have been 
implicated (Moran and Hollows, 1984; Johnson, 
2003), pterygium has been unequivocally shown to 
be caused by ultra violet light (Mackenzie et al., 
1992). Pedigree analysis has demonstrated families 
with dominant mode of inheritance, although most 
cases appear to be sporadic (Johnson, 2003). 
Pterygium has no sex predilection and rarely occurs 
in individual below 15 years. The prevalence of 
pterygium increases with age and the highest 
incidence occurs between the ages of 20 and 49 
(Hilgers, 1960). Recurrences may be more frequent 
in young adults than older individuals. The 
management of pterygium includes avoiding risk 
factors such as exposure to smoke/ dust, use of hat/ 
spectacle to block ultraviolet rays and relief of 
symptoms using topical lubricants, vasoconstrictors 
and steroids.  
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The definitive treatment is surgical excision with or 
without adjuvant therapy (Johnson, 2003; Khamar 
et al., 2005; Luanratanakorn et al., 2006). Advanced 
pterygium leading to bilateral blindness is 
uncommon and even unexpected in a setting with 
available eye care services. This present report is 
on an indigent middle aged woman living in a city 
with available eye care services. The blinding 
advanced pterygia with impact on quality of life is 
reported.  
CASE REPORT 
A 46 year old seamstress, mother of five children, 
presented at eye clinic, University of Ilorin Teaching 
Hospital (UITH), Ilorin, Nigeria on account of 
itching, redness, lacrimation and fleshy growth over 
both eyes for 10 years. She had enjoyed good vision 
until 5 years prior to presentation when she noticed 
diminishing vision. About 3 years before 
presentation, she noticed she could no longer 
thread needle and initially relied on seamstress 
trainees (apprentice) to thread needle for her. She 
also had difficulty recognising faces especially at a 
distance and subsequently was having difficulty 
identifying numbers on the tape rule for 
measurement.  
 
The progressive diminishing vision forced her to 
abandon her occupation, sewing. There was history 
of similar eye problem in her uncle who was a 
farmer. There was no history of ocular trauma, 
diabetes or hypertension. She had never used 
spectacle. During the early part of the condition she 
applied unnamed eye drops bought from a chemist 
which temporarily relieved her of itching, redness 
and lacrimation. She subsequently presented in a 
private eye care facility in Ilorin about 6 years prior 
to presentation at UITH. However, she could not 
afford the pterygium excision she was offered. 
The woman in a normal general clinical state 
presented at UITH’s eye clinic with visual acuities of 
counting fingers, right eye (OD) and 2/60, left eye 
(OS). There were inflamed bilateral nasal pterygia 
extending to temporal pupillary margin, OD and 
almost reaching temporal pupillary margin, OS 
(Figure 1). The anterior chamber and pupils 
appeared normal bilaterally. There was only 
glimpse of retina on attempted funduscopy. 
Intraocular pressure was not attempted with 
tonometer however; digital palpation appeared 
normal. A diagnosis of bilateral advanced inflamed 
pterygia was made and she was placed on steroid 
eye drops. Her vision improved to 2/60, OD and 
there was diminished redness in both eyes at 
review and 2/52 after. Subsequently, she was 
counseled for bilateral pterygia excision. She 
defaulted only to present in the clinic after 4 
months amidst a complaint of inability to raise 
needed fund for the treatment.  
Twelve days later and after concession, the patient 
had a successful bilateral pterygia excision under 
topical tetracaine and subconjunctival xylocaine 
with 1:100,000 adrenaline. The bare sclera surgical 
technique with MMC dab irrigated with normal 
saline after 1.5 minutes was employed. The eyes 
were placed on antibiotic ointment and steroid eye 
drops and followed up in the clinic. The 
histopathological report of the biopsy specimens 
confirmed bilateral pterygia (Figure 2). 
 
 
Figure 1: Bilateral Pterygia Resulting in 
Blindness in the Patien 
 
Figure 2: Photomicrograph of the Section of the 
Excisional Biopsy from the Patient 
(Haematoxylin & Eosin x400) 
 
DISCUSSION 
Advanced pterygium leading to bilateral blindness 
is uncommon and even unexpected in a setting with 
eye care resources. Hence, this report of a middle 
aged woman living in Ilorin, Nigeria illustrates the 
interplay of poverty and ignorance on pterygium 
progression leading to avoidable blindness and 
impact on source of livelihood and quality of life. 
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Pterygium does not necessarily regress in an eye 
with diminishing vision and similar case has been 
reported in an Australian aboriginal woman with a 
pterygium that covered the entire cornea, resulting 
in blindness (Taylor et al., 1978). The history of 
pterygium in this patient’s uncle may suggest 
inheritance with reduced penetrance though it may 
also be sporadic. Apparently, the protective role of 
her indoor occupation may be outweighed by 
genetic and environmental risk factors. There were 
a number of factors that clearly put the woman at 
risk of pterygium. She resides in Ilorin which is 
located on latitude 80 north of the equator (within 
the ‘pterygium belt’ of the world) (Johnson, 2003) 
and the town is dry, dusty and warm.  
Although, surgical tariffs of the teaching hospital 
are subsidised, the patient evidently belongs to the 
low socio-economic class of the society as adjudged 
by her inability to afford pterygium excision in 
private eye care facility and the teaching hospital. 
This patient’s pterygium excision was made 
possible through concession such as waving cost of 
surgery in one eye and sharing the MMC bought by 
‘have patient’ who was in the same operation list. 
Adjunctive MMC complementing bare sclera 
pterygium excision in patients with pterygia is 
known to reduce recurrence rate (Ghoneim et al., 
2011). Nevertheless, timely intervention could have 
saved her sight with consequential impact on 
quality of life. This case therefore agrees with the 
differential billing proposed by Adeoye (2002) 
whereby the hospital bills of the ‘haves’ takes care 
of the ‘have nots’. It is suggested that the private 
eye care facility should subsidise hospital bills for 
deserving indigent patients.  
 
CONCLUSION 
Pterygium is a cause of avoidable blindness and this 
present case is not isolated from what is seen in 
remote settings, nevertheless, it is amenable to 
simple excision with or without adjuvant therapy. 
Evidently, the attitudes, beliefs and practices of the 
eye care providers and the patients impact much on 
preventing blindness due pterygium.  
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